CN1151149C - 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺 - Google Patents

用于抑制细胞增殖的取代的双吲哚基马来酰亚胺 Download PDF

Info

Publication number
CN1151149C
CN1151149C CNB971967768A CN97196776A CN1151149C CN 1151149 C CN1151149 C CN 1151149C CN B971967768 A CNB971967768 A CN B971967768A CN 97196776 A CN97196776 A CN 97196776A CN 1151149 C CN1151149 C CN 1151149C
Authority
CN
China
Prior art keywords
methyl
compound
alkyl
hydrogen
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB971967768A
Other languages
English (en)
Chinese (zh)
Other versions
CN1226247A (zh
Inventor
M
唐娜·M·赫因
D
丹尼斯·D·基思
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1226247A publication Critical patent/CN1226247A/zh
Application granted granted Critical
Publication of CN1151149C publication Critical patent/CN1151149C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
CNB971967768A 1996-07-29 1997-07-19 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺 Expired - Fee Related CN1151149C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29
US60/022,079 1996-07-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNA031275400A Division CN1495182A (zh) 1996-07-29 1997-07-19 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺

Publications (2)

Publication Number Publication Date
CN1226247A CN1226247A (zh) 1999-08-18
CN1151149C true CN1151149C (zh) 2004-05-26

Family

ID=21807711

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB971967768A Expired - Fee Related CN1151149C (zh) 1996-07-29 1997-07-19 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CNA031275400A Pending CN1495182A (zh) 1996-07-29 1997-07-19 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA031275400A Pending CN1495182A (zh) 1996-07-29 1997-07-19 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺

Country Status (23)

Country Link
US (2) US5856517A (cg-RX-API-DMAC7.html)
EP (1) EP0915872B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000516589A (cg-RX-API-DMAC7.html)
KR (1) KR20000029637A (cg-RX-API-DMAC7.html)
CN (2) CN1151149C (cg-RX-API-DMAC7.html)
AR (1) AR008267A1 (cg-RX-API-DMAC7.html)
AT (1) ATE240318T1 (cg-RX-API-DMAC7.html)
AU (1) AU739742B2 (cg-RX-API-DMAC7.html)
BR (1) BR9711605A (cg-RX-API-DMAC7.html)
CA (1) CA2262092A1 (cg-RX-API-DMAC7.html)
CO (1) CO4900055A1 (cg-RX-API-DMAC7.html)
CY (1) CY2483B1 (cg-RX-API-DMAC7.html)
DE (1) DE69722003T2 (cg-RX-API-DMAC7.html)
DK (1) DK0915872T3 (cg-RX-API-DMAC7.html)
ES (1) ES2198001T3 (cg-RX-API-DMAC7.html)
HR (1) HRP970414A2 (cg-RX-API-DMAC7.html)
MA (1) MA24287A1 (cg-RX-API-DMAC7.html)
PE (1) PE91698A1 (cg-RX-API-DMAC7.html)
PT (1) PT915872E (cg-RX-API-DMAC7.html)
SA (1) SA97180473A (cg-RX-API-DMAC7.html)
TR (1) TR199900157T2 (cg-RX-API-DMAC7.html)
WO (1) WO1998004552A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA976492B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002580T2 (tr) * 1998-03-17 2000-11-21 F.Hoffmann-La Roche Ag Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
WO2001044247A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
ATE267194T1 (de) * 1999-12-16 2004-06-15 Lilly Co Eli Medikamente geeignet zur behandlung von proliferativen erkrankungen
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
SI1846406T1 (sl) 2005-02-09 2011-02-28 Arqule Inc Maleimidni derivati, farmacevtski sestavki in postopki za zdravljenje raka
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
US8232285B2 (en) 2007-06-22 2012-07-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
CA2690799C (en) 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
US8513292B2 (en) 2007-06-22 2013-08-20 Arqule, Inc. Compositions and methods for the treatment of cancer
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The Ｎ−置換アニリン誘導体及び１−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
AU2015217152A1 (en) 2014-02-11 2016-08-11 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
JP2017524739A (ja) 2014-07-17 2017-08-31 アンセルムＩｎｓｅｒｍ 神経筋接合部関連疾患の処置方法
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
AU2018290225A1 (en) * 2017-06-21 2020-01-23 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
WO1993018765A1 (en) * 1992-03-20 1993-09-30 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
US6030994A (en) 2000-02-29
US5856517A (en) 1999-01-05
KR20000029637A (ko) 2000-05-25
HRP970414A2 (en) 1998-06-30
PE91698A1 (es) 1998-12-24
EP0915872B1 (en) 2003-05-14
BR9711605A (pt) 1999-08-24
CY2483B1 (en) 2005-06-03
DE69722003T2 (de) 2004-04-01
CO4900055A1 (es) 2000-03-27
ZA976492B (en) 1998-01-29
PT915872E (pt) 2003-09-30
SA97180473A (ar) 2005-12-03
DE69722003D1 (de) 2003-06-18
JP2000516589A (ja) 2000-12-12
WO1998004552A1 (en) 1998-02-05
ES2198001T3 (es) 2004-01-16
EP0915872A1 (en) 1999-05-19
AU3769097A (en) 1998-02-20
AR008267A1 (es) 1999-12-29
MA24287A1 (fr) 1998-04-01
TR199900157T2 (xx) 1999-04-21
CA2262092A1 (en) 1998-02-05
AU739742B2 (en) 2001-10-18
CN1495182A (zh) 2004-05-12
CN1226247A (zh) 1999-08-18
ATE240318T1 (de) 2003-05-15
DK0915872T3 (da) 2003-09-08

Similar Documents

Publication Publication Date Title
CN1151149C (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CN1077571C (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CA2917965C (fr) Nouveaux derives d'indole et de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1671694A (zh) 作为激酶抑制剂的二吲哚基－顺丁烯二酰亚胺衍生物
CN1044909C (zh) 吲哚衍生物
EA027242B1 (ru) ЗАМЕЩЕННЫЕ 3,4-ДИГИДРО-2H-ПИРИДО[1,2-a]ПИРАЗИН-1,6-ДИОНОВЫЕ ПРОИЗВОДНЫЕ, ПРИМЕНИМЫЕ ДЛЯ ЛЕЧЕНИЯ (В ТОМ ЧИСЛЕ) БОЛЕЗНИ АЛЬЦГЕЙМЕРА
CN1127500C (zh) 抑制细胞增殖的取代双吲哚基马来酰亚胺
CN101784542A (zh) 咪唑酮衍生物、制备方法及生物用途
CN1158283C (zh) 作为蛋白激酶抑制剂的4-和5-吡嗪基羟吲哚
CN1065460A (zh) 衍生于苯并咪唑的新的非镇静抗组胺剂
CN1134695A (zh) 具有血小板凝聚抑制作用的新颖化合物
HUP0203524A2 (hu) Daganatellenes hatású 2- (1H-indol-3-il)-2-oxo-acetamidok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
JP2007529474A (ja) 高血圧の処置のためのレニン阻害剤としての５−アミノ−４−ヒドロキシ−７−（１ｈ−インドールメチル）−８−メチルノンアミド誘導体
CN1742008A (zh) 抗菌的吲哚酮噁唑烷酮、它们的制备中间体和含有它们的药物组合物
CN1976925A (zh) 吡咯基嘧啶erk蛋白激酶抑制剂的前体药物
CN1237176A (zh) 用作fpt抑制剂的三环化合物
CN1226249A (zh) 用于抑制细胞增殖的取代的双吲哚基马来酰亚胺
CN1267288A (zh) 用作法呢基蛋白转移酶抑制剂的三环酮酰胺衍生物
CN1330654A (zh) 4,5－吡咯并羟吲哚
CN1193027C (zh) 取代的吡咯类化合物
CN1267290A (zh) 新的法呢基－蛋白转移酶的三环磺酰胺抑制剂
CN1378545A (zh) 作为用于治疗癌症的抗增殖剂的取代的吡咯类化合物
CN103228644B (zh) Ccr2的4-取代-环己基氨基-4-哌啶基-乙酰胺拮抗剂
CN1229374C (zh) 用于抑制细胞增殖的取代的二吲哚基马来酰亚胺
CN1106400C (zh) 抗肿瘤吲哚并吡咯并咔唑衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee